Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesA biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Coinbase stock has fallen sharply this year, yet a cadre of analysts believes a turnaround is possible as the company...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
Energy giants Chevron and ExxonMobil trade at new levels, with investors weighing cash flow, LNG ramp-ups, and recent...
A bold forecast from Moonshot AI’s Kimi model envisions a wide end-2026 Bitcoin range, with potential upside to $180,...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
Palantir shares slip in a broad software selloff, brushing near key support as investors weigh growth prospects again...
Circle just cleared a major regulatory milestone with a national bank charter. This could reshape how CRCL stock move...
Memory prices still skyrocketing have traders eyeing a new phase for Micron, SanDisk, and SK Hynix amid lingering sup...
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
SOL broke past $93, turning a weeks-long distribution zone into a potential floor. Analysts warn a quick squeeze coul...